In line with other oncological studies, several groups have found that overall prognosis and survival were significantly improved when tumors – either HCC or CCA – expressed relatively greater amounts of RECK (11, 29, 33, 35). The gene discussed is RECK; the disease is hepatocellular carcinoma.